NR4A1 and ovarian cancer: However, no differences in immunohistochemical ER and PR staining were observed between tumours derived from fresh and stored tumour tissue, suggesting that neither storage nor the percentage of FCS in the freezing solution influenced the hormone receptor status of these ovarian cancer PDXs.